← Leaderboards
Steven Terry Rosen
Beckman Research Institute/City Of Hope
$39,410,931
Attributed
$41,215,546
Total exposure
47
Grants
46
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.5M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$146,965,017 · 50
By mechanism
P30$119,636,319 · 41
U54$11,537,960 · 1
R01$11,265,191 · 4
T32$2,875,394 · 1
U01$1,312,527 · 1
R21$302,490 · 1
Top collaborators
- Chad A. Mirkin8 shared
- Flavia Pichiorri4 shared
- Michael Rosenzweig4 shared
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Hirotake Komatsu$2,743,808
Others in their field
Top investigators on “Cancer Center”
- Leonard Freedman · Leidos Biomedical Research, Inc.$885,275,552
- David Heimbrook · Leidos Biomedical Research, Inc.$793,360,762
- Larry Arthur$473,862,081
- Richard A Gibbs · Baylor College Of Medicine$257,275,004
- Lynn Briscoe · Leidos Biomedical Research, Inc.$248,567,868
- Norman Wolmark · Nsabp Foundation, Inc.$237,419,252
Research focus
Cancer CenterProgramsResource SharingResourcesComprehensive Cancer CenterMemberResearch PersonnelMalignant NeoplasmsFundingFacultyMissionLeadershipInstitutionBaseCancer Center Support GrantStructureUniversitiesClinical ResearchInnovationGenomicsHematologic NeoplasmsMedical CenterServicesBasic Science
Grant awards (200)
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans$677,645
R01 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$321,568
P30 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$307,092
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant$1,134,816
P30 · FY2023 · CA · contact PI
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy$678,014
R01 · FY2023 · CA · contact PI
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans$653,591
R01 · FY2023 · CA · contact PI
Leadership, Planning and Evaluation$232,368
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant$3,408,187
P30 · FY2022 · CA · contact PI
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy$678,014
R01 · FY2022 · CA · contact PI
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans$656,771
R01 · FY2022 · CA · contact PI
Leadership, Planning and Evaluation$400,753
P30 · FY2022 · CA · contact PI
Novel targeted therapies for HPV-associated Non-AIDS-defining cancers (Biospecimens/Biocohort)$250,000
P30 · FY2022 · CA · contact PI
Genomic and Microenvironment Analysis of HIV-Associated Diffuse Large B-cell Lymphoma (Immuno/Microenvironment)$249,999
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$3,408,187
P30 · FY2021 · CA · contact PI
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans$718,916
R01 · FY2021 · CA · contact PI
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy$691,849
R01 · FY2021 · CA · contact PI
Leadership, Planning and Evaluation$400,753
P30 · FY2021 · CA · contact PI
Creating an Efficient Clinical Trial Build System Via the Clinical Trials Rapid Activation Consortium (CTRAC)$300,003
P30 · FY2021 · CA · contact PI
Caribbean Investigation of Cancer Stigma and its effect on Cervical Cancer Screening and HPV Vaccination$219,626
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$3,558,187
P30 · FY2020 · CA · contact PI
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy$691,849
R01 · FY2020 · CA · contact PI
A Phase 2 Trial of Leflunomide for the Treatment of COVIDâ19 in Patients with Solid Tumors and Hematologic Malignancies$440,000
P30 · FY2020 · CA · contact PI
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia$430,489
R01 · FY2020 · CA · contact PI
Leadership, Planning and Evaluation$407,895
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$391,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$385,000
P30 · FY2020 · CA · contact PI
Creating an Efficient Clinical Trial Build System Via the Clinical Trials Rapid Activation Consortium (CTRAC)$299,998
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$3,315,286
P30 · FY2019 · CA · contact PI
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy$691,849
R01 · FY2019 · CA · contact PI
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia$434,681
R01 · FY2019 · CA · contact PI
Leadership, Planning and Evaluation$389,830
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$31,250
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$2,543,187
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$865,000
P30 · FY2018 · CA · contact PI
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia$479,954
R01 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$299,041
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$43,750
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$2,083
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$2,446,682
P30 · FY2017 · CA · contact PI
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia$463,530
R01 · FY2017 · CA · contact PI
Cancer Center Support Grant$124,999
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$73,297
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$2,520,000
P30 · FY2016 · CA · contact PI
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia$499,409
R01 · FY2016 · CA · contact PI
Cancer Center Support Grant$350,000
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$125,651
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$124,999
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$37,400
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$2,184,600
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$124,999
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$113,085
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$53,400
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$50,000
P30 · FY2015 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,190,152
U54 · FY2014 · CA
Cancer Center Support Grant$2,119,061
P30 · FY2014 · CA · contact PI
Cancer Center Support Grant$126,241
P30 · FY2014 · CA · contact PI
Cancer Center Support Grant$121,881
P30 · FY2014 · CA · contact PI
Cancer Center Support Grant$64,080
P30 · FY2014 · CA · contact PI
Cancer Center Support Grant$12,600
P30 · FY2014 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,130,727
U54 · FY2013 · CA
SENIOR LEADERSHIP$541,026
P30 · FY2013 · CA · contact PI
Administration$481,447
P30 · FY2013 · CA · contact PI
Development Funds$406,596
P30 · FY2013 · CA · contact PI
CLINICAL RESEARCH OFFICE$402,623
P30 · FY2013 · CA · contact PI
Program leaders$360,485
P30 · FY2013 · CA · contact PI
BIOSTATISTICS CORE FACILITY$287,745
P30 · FY2013 · CA · contact PI
PATHOLOGY CORE FACILITY$259,059
P30 · FY2013 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$175,149
P30 · FY2013 · CA · contact PI
Molecular & Translational Imaging Core$152,622
P30 · FY2013 · CA · contact PI
STRUCTURAL BIOLOGY FACILITY$152,163
P30 · FY2013 · CA · contact PI
Keck Biophysics Facility$150,127
P30 · FY2013 · CA · contact PI
TRANSGENIC AND TARGETED MUTAGENESIS LABORATORY$139,029
P30 · FY2013 · CA · contact PI
Cell Imaging Facility$136,533
P30 · FY2013 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$131,719
P30 · FY2013 · CA · contact PI
CANCER INFORMATICS CORE$128,718
P30 · FY2013 · CA · contact PI
High Throughput Analysis Laboratory$128,236
P30 · FY2013 · CA · contact PI
Developmental Therapeutics Core Facility$127,933
P30 · FY2013 · CA · contact PI
MOUSE HISTOLOGY & PHENOTYPING LABORATORY$125,108
P30 · FY2013 · CA · contact PI
Flow Cytometry Facility$118,274
P30 · FY2013 · CA · contact PI
Medicinal & Synthetic Chemistry Core$96,447
P30 · FY2013 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$75,000
P30 · FY2013 · CA · contact PI
CTRP$75,000
P30 · FY2013 · CA · contact PI
OUTCOMES MEASUREMENT & SURVEY CORE FACILITY$65,078
P30 · FY2013 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$53,972
U54 · FY2013 · CA
The Robert H. Lurie Comprehensive Cancer Center$50,000
P30 · FY2013 · CA · contact PI
CTLA$50,000
P30 · FY2013 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$35,157
P30 · FY2013 · CA · contact PI
PLANNING AND EVALUATION$34,404
P30 · FY2013 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$4,829,857
P30 · FY2012 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,318,024
U54 · FY2012 · CA
developmental Funds$500,019
P30 · FY2012 · CA · contact PI
Administration$444,789
P30 · FY2012 · CA · contact PI
Senior Leadership$413,385
P30 · FY2012 · CA · contact PI
Program Leaders$322,069
P30 · FY2012 · CA · contact PI
Clinical Oncology Research Training Program$257,082
T32 · FY2012 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$201,725
P30 · FY2012 · CA · contact PI
keck biophysics$191,556
P30 · FY2012 · CA · contact PI
transgenic and targeted mutagenesis$185,502
P30 · FY2012 · CA · contact PI
genomics$185,216
P30 · FY2012 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$169,210
P30 · FY2012 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$107,937
P30 · FY2012 · CA · contact PI
Planning and evaluation$107,588
P30 · FY2012 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$76,389
P30 · FY2012 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$75,000
P30 · FY2012 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$57,724
U54 · FY2012 · CA
The Robert H. Lurie Comprehensive Cancer Center$4,829,858
P30 · FY2011 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,329,637
U54 · FY2011 · CA
developmental Funds$705,662
P30 · FY2011 · CA · contact PI
Senior Leadership$549,549
P30 · FY2011 · CA · contact PI
Program Leaders$453,221
P30 · FY2011 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$322,077
P30 · FY2011 · CA · contact PI
Clinical Oncology Research Training Program$192,050
T32 · FY2011 · CA · contact PI
keck biophysics$176,430
P30 · FY2011 · CA · contact PI
genomics$174,839
P30 · FY2011 · CA · contact PI
Chicago Cancer Navigation Project$169,999
U01 · FY2011 · CA · contact PI
transgenic and targeted mutagenesis$155,267
P30 · FY2011 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$136,587
P30 · FY2011 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$75,000
P30 · FY2011 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$73,178
P30 · FY2011 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$72,130
P30 · FY2011 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$57,724
U54 · FY2011 · CA
Planning and evaluation$42,355
P30 · FY2011 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$5,047,305
P30 · FY2010 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,400,000
U54 · FY2010 · CA
developmental Funds$740,479
P30 · FY2010 · CA · contact PI
Senior Leadership$576,656
P30 · FY2010 · CA · contact PI
Program Leaders$475,575
P30 · FY2010 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$337,960
P30 · FY2010 · CA · contact PI
Clinical Oncology Research Training Program$251,839
T32 · FY2010 · CA · contact PI
keck biophysics$185,125
P30 · FY2010 · CA · contact PI
genomics$183,456
P30 · FY2010 · CA · contact PI
transgenic and targeted mutagenesis$162,919
P30 · FY2010 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$143,317
P30 · FY2010 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$100,000
P30 · FY2010 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$76,778
P30 · FY2010 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$75,066
P30 · FY2010 · CA · contact PI
Chicago Cancer Navigation Project$60,000
U01 · FY2010 · CA · contact PI
Planning and evaluation$44,434
P30 · FY2010 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$5,084,061
P30 · FY2009 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$1,485,341
P30 · FY2009 · CA · contact PI
developmental Funds$757,385
P30 · FY2009 · CA · contact PI
Chicago Cancer Navigation Project$655,253
U01 · FY2009 · CA · contact PI
Senior Leadership$589,821
P30 · FY2009 · CA · contact PI
Program Leaders$486,431
P30 · FY2009 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$345,671
P30 · FY2009 · CA · contact PI
Adenosine Analogs: Therapeutics for Hematologic Cancers$311,259
R01 · FY2009 · CA · contact PI
Chicago Cancer Navigation Project$301,882
U01 · FY2009 · CA · contact PI
Clinical Oncology Research Training Program$222,637
T32 · FY2009 · CA · contact PI
keck biophysics$189,345
P30 · FY2009 · CA · contact PI
genomics$187,638
P30 · FY2009 · CA · contact PI
transgenic and targeted mutagenesis$166,629
P30 · FY2009 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$146,580
P30 · FY2009 · CA · contact PI
Chicago Cancer Navigation Project$125,393
U01 · FY2009 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$99,471
P30 · FY2009 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$83,979
P30 · FY2009 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$78,521
P30 · FY2009 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$73,969
P30 · FY2009 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$50,000
P30 · FY2009 · CA · contact PI
Planning and evaluation$45,439
P30 · FY2009 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$5,084,061
P30 · FY2008 · CA · contact PI
developmental Funds$752,689
P30 · FY2008 · CA · contact PI
Senior Leadership$586,168
P30 · FY2008 · CA · contact PI
Program Leaders$483,419
P30 · FY2008 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$343,537
P30 · FY2008 · CA · contact PI
Adenosine Analogs: Therapeutics for Hematologic Cancers$311,663
R01 · FY2008 · CA · contact PI
Clinical Oncology Research Training Program$229,438
T32 · FY2008 · CA · contact PI
keck biophysics$188,183
P30 · FY2008 · CA · contact PI
genomics$186,483
P30 · FY2008 · CA · contact PI
transgenic and targeted mutagenesis$165,606
P30 · FY2008 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$145,686
P30 · FY2008 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$91,948
P30 · FY2008 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$83,152
P30 · FY2008 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$78,048
P30 · FY2008 · CA · contact PI
Adenosine Analogs: Therapeutics for Hematologic Cancers$51,498
R01 · FY2008 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$49,383
P30 · FY2008 · CA · contact PI
Planning and evaluation$45,173
P30 · FY2008 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$5,033,724
P30 · FY2007 · CA · contact PI
Senior Leadership$788,780
P30 · FY2007 · CA · contact PI
developmental Funds$650,829
P30 · FY2007 · CA · contact PI
Administration$535,128
P30 · FY2007 · CA · contact PI
Program Leaders$417,997
P30 · FY2007 · CA · contact PI
Adenosine Analogs: Therapeutics for Hematologic Cancers$312,066
R01 · FY2007 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$297,044
P30 · FY2007 · CA · contact PI
Clinical Oncology Research Training Program$244,431
T32 · FY2007 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$216,819
P30 · FY2007 · CA · contact PI
keck biophysics$162,714
P30 · FY2007 · CA · contact PI
genomics$161,247
P30 · FY2007 · CA · contact PI
transgenic and targeted mutagenesis$143,193
P30 · FY2007 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$125,966
P30 · FY2007 · CA · contact PI
The Robert H.Lurie Comprehensive Cancer Center$90,600
P30 · FY2007 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$67,482
P30 · FY2007 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$66,034
P30 · FY2007 · CA · contact PI
Adenosine Analogs: Therapeutics for Hematologic Cancers$51,498
R01 · FY2007 · CA · contact PI
Planning and evaluation$39,055
P30 · FY2007 · CA · contact PI
The Robert H.Lurie Comprehensive Cancer Center$4,465,353
P30 · FY2006 · CA · contact PI
Adenosine Analogs: Therapeutics for Hematologic Cancers$321,801
R01 · FY2006 · CA · contact PI